130 related articles for article (PubMed ID: 20225928)
21. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis.
Sanelli T; Xiao S; Horne P; Bilbao J; Zinman L; Robertson J
J Neuropathol Exp Neurol; 2007 Dec; 66(12):1147-53. PubMed ID: 18090923
[TBL] [Abstract][Full Text] [Related]
22. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.
Geser F; Stein B; Partain M; Elman LB; McCluskey LF; Xie SX; Van Deerlin VM; Kwong LK; Lee VM; Trojanowski JQ
Acta Neuropathol; 2011 Apr; 121(4):509-17. PubMed ID: 21225272
[TBL] [Abstract][Full Text] [Related]
23. Alterations in subcellular localization of TDP-43 immunoreactivity in the anterior horns in sporadic amyotrophic lateral sclerosis.
Sasaki S; Takeda T; Shibata N; Kobayashi M
Neurosci Lett; 2010 Jul; 478(2):72-6. PubMed ID: 20447446
[TBL] [Abstract][Full Text] [Related]
24. The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons.
Yamashita T; Hideyama T; Teramoto S; Kwak S
Neurosci Res; 2012 Jun; 73(2):153-60. PubMed ID: 22414730
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS.
Krach F; Batra R; Wheeler EC; Vu AQ; Wang R; Hutt K; Rabin SJ; Baughn MW; Libby RT; Diaz-Garcia S; Stauffer J; Pirie E; Saberi S; Rodriguez M; Madrigal AA; Kohl Z; Winner B; Yeo GW; Ravits J
Acta Neuropathol; 2018 Sep; 136(3):405-423. PubMed ID: 29881994
[TBL] [Abstract][Full Text] [Related]
26. Co-localization of Bunina bodies and TDP-43 inclusions in lower motor neurons in amyotrophic lateral sclerosis.
Mori F; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2014 Feb; 34(1):71-6. PubMed ID: 23711197
[TBL] [Abstract][Full Text] [Related]
27. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis.
Suzuki M; Mikami H; Watanabe T; Yamano T; Yamazaki T; Nomura M; Yasui K; Ishikawa H; Ono S
Acta Neurol Scand; 2010 Nov; 122(5):367-72. PubMed ID: 20175762
[TBL] [Abstract][Full Text] [Related]
29. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
[TBL] [Abstract][Full Text] [Related]
30. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
Kwak S
Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
[TBL] [Abstract][Full Text] [Related]
31. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.
Chennampally P; Sayed-Zahid A; Soundararajan P; Sharp J; Cox GA; Collins SD; Smith RL
Sci Rep; 2021 Sep; 11(1):18168. PubMed ID: 34518579
[TBL] [Abstract][Full Text] [Related]
32. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
33. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
[TBL] [Abstract][Full Text] [Related]
34. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
[TBL] [Abstract][Full Text] [Related]
35. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis.
Mori F; Tanji K; Miki Y; Wakabayashi K
J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197
[TBL] [Abstract][Full Text] [Related]
36. [Optogenetic interrogation of TDP-43 cytotoxicity in a zebrafish ALS model].
Asakawa K; Handa H; Kawakami K
Nihon Yakurigaku Zasshi; 2023; 158(1):16-20. PubMed ID: 36596480
[TBL] [Abstract][Full Text] [Related]
37. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
38. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
Shan X; Vocadlo D; Krieger C
Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
[TBL] [Abstract][Full Text] [Related]
39. Endocytosis regulates TDP-43 toxicity and turnover.
Liu G; Coyne AN; Pei F; Vaughan S; Chaung M; Zarnescu DC; Buchan JR
Nat Commun; 2017 Dec; 8(1):2092. PubMed ID: 29233983
[TBL] [Abstract][Full Text] [Related]
40. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
